Results 81 to 90 of about 830,210 (192)
Spectrophotometric determination of cholinesterase activity using carbamate inhibitors [PDF]
Charles University, Faculty o Pharmacy in Hradec Králové Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Student: Ondřej Keresteš Supervisor: PharmDr. Marta Kučerová, Ph.D. Consultant: pplk. prof. RNDr.
Keresteš, Ondřej
core
ABSTRACT Background Blood pressure variability (BPV) is an established predictor of cardiovascular risk, yet its physiologic determinants in specific populations remain incompletely defined. Neurodegenerative diseases are associated with autonomic dysfunction that may alter blood pressure regulation.
Wesley Smith +5 more
wiley +1 more source
Clinical Trajectory of Late‐Onset Delusional Disorder Toward Evolving Dementia With Lewy Bodies
ABSTRACT Recent clinical observations indicate that late‐onset psychosis can precede the onset of dementia with Lewy bodies (DLB). However, its longitudinal clinical trajectory remains poorly understood. Delusional disorder (DD) in older adults is relatively uncommon and poor insight frequently leads to refusal of psychiatric care, limiting available ...
Hiroshige Fujishiro +7 more
wiley +1 more source
Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimer
Cholinesterase inhibitors constitute one of few treatment options available for Alzheimer Simulation models can be used to bring together existing data and make predictions of the long-term cost effectiveness of treatment.
Linus Jonsson
core
In an effort to develop new and effective therapeutic agents for Alzheimer's disease, a series of hydrazone derivatives bearing piperidine rings have been designed and synthesized.
Tatar Yılmaz, Gizem +8 more
core +1 more source
Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]
Heo RJ +8 more
europepmc +2 more sources
Isatin derivatives as potent cholinesterase inhibitors: recent developments and future challenges. [PDF]
Shahzad M +3 more
europepmc +1 more source
Cholinesterase inhibitors in advanced Dementia with Lewy bodies: increase or stop?
Introduction There is little data on stopping cholinesterase inhibitors in Dementia with Lewy bodies (DLB). Equally, it is not known if increasing the dose of cholinesterase inhibitors may help neuropsychiatric symptoms in advanced DLB.
Cousins DA +7 more
core +3 more sources
Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the trial with cholinesterase inhibitors ...
Tomasz Sobow
core
Rhodanine and 2,4-dioxothiazolidine-based amides: synthesis and evaluation as dual-action cholinesterase inhibitors and antioxidants. [PDF]
Šikorová E +5 more
europepmc +1 more source

